Understanding the modulation of specific immune cells within the tumor microenvironment (TME) offers new hope in cancer treatments, especially in cancer immunotherapies. In recent years, immune modulation and resistance to immunotherapy have become critical challenges in cancer treatments. However, novel strategies for immune modulation have emerged as promising approaches for oncology due to the vital roles of the immunomodulators in regulating tumor progression and metastasis and modulating immunological responses to standard of care in cancer treatments. With the progress in immuno-oncology, a growing number of novel immunomodulators and mechanisms are being uncovered, offering the potential for enhanced clinical immunotherapy in the near future. Thus, gaining a comprehensive understanding of the broader context is essential. Herein, we particularly summarize the paradoxical role of tumor-related immune cells, focusing on how targeted immune cells and their actions are modulated by immunotherapies to overcome immunotherapeutic resistance in tumor cells. We also highlight the molecular mechanisms employed by tumors to evade the long-term effects of immunotherapeutic agents, rendering them ineffective.

Micro(nano)plastics (MNPs) are globally ubiquitous environmental pollutants that have become a growing concern for human health, but their potential role in human carcinogenesis remains to be determined. Over the past few years, MNPs have been identified as potential carcinogenic and mutagenic agents in various human samples as they induce oxidative stress, DNA damage, and immune dysregulation, which can alter the tumor microenvironment, thereby promoting cancer development and metastasis. Researchers are actively investigating the health risks posed by MNP particles in order to establish clearer links between MNP exposure and the onset of various human cancers. Although recent research suggests a potential tumorigenic connection between MNPs and some cancer types like skin, lung, breast and gastrointestinal cancers, further studies are required to clarify their long-term effects and specific mechanisms. In our review, we provide an overview of the current state of knowledge regarding the carcinogenic impacts of MNPs and the underlying molecular mechanisms through which MNP exposure may contribute to human cancer progression. Additionally, we highlight existing knowledge gaps and provide important recommendations for future research on the carcinogenic potential of MNPs.